You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

TEL/ALM1_positive ALL relapses

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Lymphoblastic Leukemia (ALL) Trial in Rennes (Impact of CD9 expression level on motility assays, Post-transcriptional

Completed
  • Acute Lymphoblastic Leukemia (ALL)
  • Impact of CD9 expression level on motility assays
  • Post-transcriptional regulation of CD9
  • Rennes, France
    Rennes University Hospital
Aug 11, 2020

Acute Demyelinating Syndrome Trial in France (Immediate Azathioprine (1st attack), Immediate Rituximab (1st attack), Standard of

Not yet recruiting
  • Acute Demyelinating Syndrome
  • Immediate Azathioprine (1st attack)
  • +2 more
  • Besançon, France
  • +8 more
Sep 14, 2022

The Relapses in Childhood Acute Lymphoplastic Leukemia Excluding

Completed
  • Leukemia, Acute
    • (no location specified)
    Jul 23, 2023

    B-cell Acute Lymphoblastic Leukemia, B-cell Lymphoma, Diffuse Large B Cell Lymphoma Trial in Beijing (CD19/CD22-bispecific CAR-T

    Recruiting
    • B-cell Acute Lymphoblastic Leukemia
    • +2 more
    • CD19/CD22-bispecific CAR-T cells
    • Beijing, Beijing, China
      Liang Wang
    Oct 7, 2023

    Lymphoblastic Lymphoma, Childhood Trial in Worldwide (Cyclophosphamide, Cytarabine, Dexamethasone)

    Recruiting
    • Lymphoblastic Lymphoma, Childhood
    • Graz, Austria
    • +222 more
    Dec 13, 2022

    Relapses in Multiple Sclerosis (MS) and Vitamin D Intake

    Completed
    • Multiple Sclerosis
      • Peoria, Illinois
        OSF Saint Francis Medical Center
      Apr 22, 2022

      Diroximel Fumarate Real-world Experience in Canada and Israel

      Recruiting
      • Relapsing Forms of MS
      • Diroximel Fumarate
      • Haifa, Israel
      • +5 more
      Jan 31, 2023

      Triple Negative Breast Cancer Trial (Sacituzumab govitecan, Pembrolizumab)

      Not yet recruiting
      • Triple Negative Breast Cancer
      • (no location specified)
      Oct 5, 2023

      Multiple Myeloma Trial in Miami (Teclistamab, Talquetamab, Daratumumab SC)

      Not yet recruiting
      • Multiple Myeloma
      • Miami, Florida
        University of Miami
      Oct 20, 2023

      HIV, Medication Adherence Trial in Bangalore (Tel-me-box with reminder features, Tel-me-box)

      Active, not recruiting
      • HIV
      • Medication Adherence
      • Tel-me-box with reminder features
      • Tel-me-box
      • Bangalore, Karnataka, India
        St. John & Research Institute/St John & Medical College & Hospit
      Feb 22, 2022

      Axial Spondyloarthritis Trial in Bothell (Dietary recommendations)

      Terminated
      • Axial Spondyloarthritis
      • Dietary recommendations
      • Bothell, Washington
        Viome Research Institute online: https://www.viome.com/VRI/studi
      Jul 5, 2022

      Primary Prevention Trial in Kiryat Shmona (Experimental: Prevention Program "young In Favor of Myself", active parents,

      Completed
      • Primary Prevention
      • Experimental: Prevention Program "young In Favor of Myself", active parents
      • Experimental: Prevention Program "young In Favor of Myself", no parental involvement
      • Kiryat Shmona, North Of Israel, Israel
        Tel Hai Academic College
      Jan 21, 2022

      Acute Lymphoblastic Leukemia, Pediatric Trial in Worldwide (Blinatumomab, Bortezomib, Cyclophosphamide)

      Recruiting
      • Acute Lymphoblastic Leukemia, Pediatric
      • Sydney, Australia
      • +114 more
      Nov 1, 2022

      Benign Brain Tumors, Proton Therapy Trial in Caen (MRI 3 tesla)

      Active, not recruiting
      • Benign Brain Tumors
      • Proton Therapy
      • MRI 3 tesla
      • Caen, France
        Centre François Baclesse
      Jan 5, 2023

      Offspring Neurocognitive Development and Behaviour

      Recruiting
      • Multiple Sclerosis
      • Exposure to methylprednisolone during pregnancy
      • Bochum, Germany
      • +1 more
      Aug 8, 2022

      Therapy Related Leukemia Trial in Guangdong (Sequential Treatment With different CART)

      Recruiting
      • Therapy Related Leukemia
      • Sequential Treatment With different CART
      • Guangdong, Guangdong, China
        Southern Medical University Zhujiang Hospital
      Aug 9, 2021

      Knee Ligament Injury Trial (goniometer, clamshells exercises, traditional physical therapy)

      Not yet recruiting
      • Knee Ligament Injury
      • goniometer
      • +2 more
      • (no location specified)
      May 11, 2023

      Vaccines in Italian MS Patients

      Recruiting
      • Multiple Sclerosis
        • Siena, SI, Italy
          university of Siena
        Nov 15, 2022

        Primary Prevention Trial in Kiryat Shmona (Experimental: "Young Millie" prevention program, active teachers, Prevention program:

        Enrolling by invitation
        • Primary Prevention
        • Experimental: "Young Millie" prevention program, active teachers
        • Prevention program: "Young Mili", non active teachers
        • Kiryat Shmona, Upper Galilee, Israel
          Tel Hai College
        Oct 23, 2021

        Ulcerative Colitis Trial (Oncostatin M)

        Not yet recruiting
        • Ulcerative Colitis
        • Oncostatin M
        • (no location specified)
        Jul 26, 2023

        Refractory Acute Myeloid Leukemia Trial in Paris (Sequential Packaging (SET), Transfusion graft, Prevention of GVHD)

        Completed
        • Refractory Acute Myeloid Leukemia
        • Sequential Packaging (SET)
        • +4 more
        • Paris, France
          Service d'hématologie Clinique Hôpital Saint Antoine
        Jul 22, 2022

        Primary Prevention Trial in Kiryat Shmona (Experimental: Prevention Program "young In Favor of Myself", active teachers,

        Enrolling by invitation
        • Primary Prevention
        • Experimental: Prevention Program "young In Favor of Myself", active teachers
        • Experimental: Prevention Program "young In Favor of Myself", no teacher involvement
        • Kiryat Shmona, Upper Galilee, Israel
          Tel Hai College
        Aug 19, 2021

        Multiple Sclerosis, Secondary Progressive, Multiple Sclerosis Trial in Warsaw (Cladribine Subcutaneous Injection, 0.9% Chloride

        Recruiting
        • Multiple Sclerosis, Secondary Progressive
        • Multiple Sclerosis
        • Cladribine Subcutaneous Injection
        • 0.9% Chloride Injection Sodium
        • Warsaw, Mazowieckie, Poland
          Institute of Psychiatry and Neurology
        Jul 26, 2023

        Giant Cell Arteritis Trial in Bonn (Methotrexate, Sodium chloride)

        Recruiting
        • Giant Cell Arteritis
        • Bonn, Germany
          Medical Clinic and Polyclinic III Internal medicine Oncology, He
        Dec 16, 2022

        Prophylactic HQP1351 Therapy, Third Generation TKI Trial in Guanzhou (HQP1351( Olverembatinib dimesylate))

        Withdrawn
        • Prophylactic HQP1351 Therapy
        • Third Generation TKI
        • HQP1351( Olverembatinib dimesylate)
        • Guanzhou, China
          Department of Hematology, Nanfang Hospital, Southern Medical Uni
        Jan 16, 2023